Bioorganic and Medicinal Chemistry p. 2152 - 2157 (2012)
Update date:2022-07-29
Topics:
Kongkamnerd, Jarinrat
Cappelletti, Luca
Prandi, Adolfo
Seneci, Pierfausto
Rungrotmongkol, Thanyada
Jongaroonngamsang, Nutthapon
Rojsitthisak, Pornchai
Frecer, Vladimir
Milani, Adelaide
Cattoli, Giovanni
Terregino, Calogero
Capua, Ilaria
Beneduce, Luca
Gallotta, Andrea
Pengo, Paolo
Fassina, Giorgio
Miertus, Stanislav
De-Eknamkul, Wanchai
Evidences of oseltamivir resistant influenza patients raised the need of novel neuraminidase inhibitors. In this study, five oseltamivir analogs PMC-31-PMC-36, synthesised according to the outcomes of a rational design analysis aimed to investigate the effects of substitution at the 5-amino and 4-amido groups of oseltamivir on its antiviral activity, were screened for their inhibition against neuraminidase N1 and N3. The enzymes used as models were from the avian influenza A H7N1 and H7N3 viruses. The neuraminidase inhibition assay was carried out by using recombinant species obtained from a baculovirus expression system and the fluorogenic substrate MUNANA. The assay was validated by using oseltamivir carboxylate as a reference inhibitor. Among the tested compounds, PMC-36 showed the highest inhibition on N1 with an IC50 of 14.6 ± 3.0 nM (oseltamivir 25 ± 4 nM), while PMC-35 showed a significant inhibitory effect on N3 with an IC50 of 0.1 ± 0.03 nM (oseltamivir 0.2 ± 0.02 nM). The analysis of the inhibitory properties of this panel of compounds allowed a preliminary assessment of a structure-activity relationship for the modification of the 4-amido and 5-amino groups of oseltamivir carboxylate. The substitution of the acetamido group in the oseltamivir structure with a 2-butenylamido moiety reduced the observed activity, while the introduction of a propenylamido group was well tolerated. Substitution of the free 5-amino group of oseltamivir carboxylate with an azide, decreased the activity against both N1 and N3. When these structural changes were both introduced, a dramatic reduction of activity was observed for both N1 and N3. The alkylation of the free 5-amino group in oseltamivir carboxylate introducing an isopropyl group seemed to increase the inhibitory effect for both N1 and N3 neuraminidases, displaying a more pronounced effect against N1.
View MoreContact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
website:http://www.gihichemicals.com
Contact:+86-571-86217390
Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Jiaxing Anrui Material Technology Co., Ltd.
Contact:86-573-82651652 13305832579
Address:Room 407, Technology Building, 1369 Chennan Road, Jiaxing City, Zhejiang, China
Contact:86-316-2098955,6896679
Address:No.89,Xinhua Road, Langfang City,Hebei China
Doi:10.1016/S0040-4039(00)92711-4
(1991)Doi:10.1021/ja01014a054
(1968)Doi:10.1021/ja3002666
(2012)Doi:10.1039/c2cc17799d
(2012)Doi:10.1016/j.chembiol.2011.05.008
(2011)Doi:10.1080/14786419.2018.1499640
(2019)